Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Von Hippel-Lindau binding protein 1 pseudogene (ENSG00000273644) is a processed or non-processed pseudogene resembling the functional VBP1 gene. Pseudogenes are classified as genomic DNA sequences similar to normal genes but nonfunctional due to disabling mutations or lack of regulatory elements, and thus do not encode functional proteins. This particular pseudogene has no established biological function, is not implicated directly in disease, and is not a therapeutic target. Its annotation is primarily of genomic interest for gene evolution and genomic organization studies, not for pharmacology or molecular targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on von Hippel-Lindau binding protein 1 pseudogene.